Related Experiment Video
Updated: Oct 15, 2026

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality
Published on: May 5, 2022
Up-regulation of gut-enriched krüppel-like factor by interferon-gamma in human colon carcinoma cells
1Section of Gastroenterology, Boston VA Medical Center and Boston University School of Medicine, E.R.B.C. Room 513, 650 Albany Street, 02118, Boston, MA, USA.
Abstract:
Interferon-gamma (IFN-gamma) induces growth arrest and apoptosis of tumor cells but the mechanisms for these functions are unknown. Recently, gut-enriched krüppel-like factor (GKLF) was found to possess similar biological properties. Treatment of HT-29 cells with IFN-gamma inhibited cell proliferation and induced apoptosis, the effect was found to associate with GKLF expression. IFN-gamma stimulates GKLF mRNA and protein levels in a dose- and time-dependent manner and this process is independent of p53, occurs rapidly and does not require de novo protein synthesis indicating that GKLF is an immediate-early IFN-gamma-responsive gene. Moreover, overexpression of GKLF results in similar effect as IFN-gamma suggesting that GKLF may function as a downstream target of IFN-gamma.
Insights
Interferon-gamma (IFN-gamma) triggers tumor cell death and growth arrest by upregulating gut-enriched krüppel-like factor (GKLF). GKLF acts as a key downstream mediator of IFN-gamma's anti-cancer effects.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Interferon-gamma (IFN-gamma) is known to induce tumor cell apoptosis and growth arrest.
- The precise molecular mechanisms underlying these effects remain largely unknown.
- Gut-enriched krüppel-like factor (GKLF) has recently emerged with similar anti-tumorigenic properties.
Purpose of the Study:
- To investigate the relationship between IFN-gamma treatment and GKLF expression in tumor cells.
- To elucidate the role of GKLF as a potential downstream mediator of IFN-gamma's anti-cancer functions.
- To understand the kinetics and regulatory pathways of GKLF induction by IFN-gamma.
Main Methods:
- Treatment of HT-29 colon cancer cells with varying doses and durations of IFN-gamma.
- Analysis of cell proliferation and apoptosis assays.
- Quantitative assessment of GKLF mRNA and protein levels.
- Investigation of p53 independence and requirement for de novo protein synthesis.
- Overexpression studies of GKLF.
Main Results:
- IFN-gamma treatment significantly inhibited HT-29 cell proliferation and induced apoptosis.
- These effects were strongly associated with increased GKLF expression.
- IFN-gamma upregulated GKLF mRNA and protein in a dose- and time-dependent manner.
- GKLF induction was rapid, independent of p53, and did not require new protein synthesis, classifying it as an immediate-early gene.
- Overexpression of GKLF mimicked the anti-proliferative and pro-apoptotic effects of IFN-gamma.
Conclusions:
- Gut-enriched krüppel-like factor (GKLF) is a critical downstream target of Interferon-gamma (IFN-gamma) in tumor cells.
- GKLF mediates the anti-proliferative and pro-apoptotic effects of IFN-gamma, suggesting its role in cancer therapy.
- The rapid, p53-independent induction of GKLF highlights its significance as an immediate-early response gene to IFN-gamma.
More Related Videos
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Inflammatory Bowel Disease II: Ulcerative Colitis